TheJobsMapQurCan Therapeutics Inc. jobs and careers
Toronto, Canada
About QurCan Therapeutics Inc.
Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents(GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
Founded in 2018 by Mohammad Ali Amini and Shirley Wu.
- Founded
- 2018
- Employees
- 1 to 10
- Total funding
- $3M
- Headquarters
- Toronto
Leadership
The top of QurCan Therapeutics Inc.'s org chart, with how many people report into each leader.
Mohammad Ali Amini
President & CEO
5 reports
Azhar Zahoor Abbasi
Executive Vice President (R&D)
3 reports
John Reid
Chief Business Officer
Jobs at QurCan Therapeutics Inc.
No open positions right now. Explore more companies on TheJobsMap.